Drupal.behaviors.print = function(context) {window.print();window.close();}>
Abbott Q2 MDx Sales Inch up 1 Percent
July 18, 2012
Abbott Q2 MDx Sales Inch up 1 Percent
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Dx Focus: Inostics OncoBEAM Blood Test; Abbott RealTime HPV Test; BioMérieux THxID BRAF assay
May 30, 2013 / PCR Insider
Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider
Study Vets Abbott Plex-ID Platform as Tool for Broad Fungal ID Directly from Clinical Specimens
March 28, 2013 / PCR Insider
On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider
Abbott's MDx Sales Rise 4 Percent in Q4
January 23, 2013 / GenomeWeb Daily News